Danaher Corporation revenue
Danaher Corporation's revenue was $24.57bn in fiscal 2025, up 2.9% on the year before. Since fiscal 2009 ($10.52bn) it has grown at a compound 5.4% a year. Over the last twelve months it was $25.61bn.
Revenue history
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.5 | 12.6 | 16.1 | 18.3 | 18.3 | 12.9 | 14.4 | 16.9 | 18.3 | 19.9 | 17.9 | 22.3 | 24.8 | 26.6 | 23.9 | 23.9 | 24.6 | 25.6 |
| Growth on the year before | — | +19.3% | +28.2% | +13.5% | +0.1% | −29.6% | +12.2% | +17.0% | +8.6% | +8.5% | −10.0% | +24.4% | +11.3% | +7.4% | −10.3% | −0.1% | +2.9% | — |
| Gross profit | 5.1 | 6.4 | 8.2 | 9.4 | 9.3 | 6.8 | 7.8 | 9.3 | 8.6 | 9.5 | 10.0 | 12.5 | 15.2 | 16.2 | 14.0 | 14.2 | 14.5 | 15.0 |
| Gross margin | 48.2% | 51.0% | 50.8% | 51.6% | 51.1% | 53.2% | 53.8% | 55.3% | 46.8% | 47.8% | 55.7% | 56.0% | 61.4% | 60.8% | 58.7% | 59.5% | 59.1% | 58.6% |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Revenuefrom Contractwith Customer Measurement Recurring | $20.1B | 81.9% | ▲ 3.9% |
| Revenuefrom Contractwith Customer Measurement Nonrecurring | $4.4B | 18.1% | ▼ 1.5% |
| Region | Revenue | Share | YoY |
|---|---|---|---|
| North America | $10.4B | 42.2% | ▲ 0.6% |
| High Growth Markets | $7B | 28.6% | ▲ 2.2% |
| Western Europe | $5.9B | 24.2% | ▲ 8.8% |
| Other Developed Markets | $1.3B | 5.1% | ▼ 0.1% |
From Danaher Corporation's 10-K filed February 24, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Danaher Corporation | $25.61bn | 5.5% | 1.3% |
| IQVIA | $17.31bn | 8.8% | 5.2% |
| Thermo Fisher Scientific | $47.35bn | 8.3% | 2.9% |
| Icon PLC | $8.25bn | 0.8% | 83.5% |
| Agilent Technologies | $7.37bn | 8.6% | 1.8% |
| Avantor, Inc. | $6.64bn | 0.9% | -1.9% |
Compare with peers
- IQVIA revenue
- Thermo Fisher Scientific revenue
- Icon PLC revenue
- Agilent Technologies revenue
- Avantor, Inc. revenue
Head to head: DHR vs IQVDHR vs TMODHR vs ICLR
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies